Device Week – European Edition
This article was originally published in The Gray Sheet
On this week's podcast, Amanda Maxwell, London-based medtech regulatory affairs editor for Clinica, provides an update and important context on the ongoing effort to significantly reform device and diagnostics oversight in the European Union. Clinica is a sister publication to "The Gray Sheet."
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.